...
首页> 外文期刊>Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus >Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses.
【24h】

Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses.

机译:局部晚期胃食管交界处和近端胃癌的术前与术后放疗:正常组织放射剂量的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Locoregional relapse occurs in over half of gastric cancer patients who undergo potentially curative resection. Adjuvant chemoradiation reduces locoregional relapse, but often requires irradiating large fields and is limited by poor patient tolerance. This study explores the potential dosimetric benefit in reducing the radiation dose to normal structures by treating gastroesophageal (GE) junction/proximal gastric cancers with preoperative rather than adjuvant radiotherapy. Five cases of GE junction/proximal gastric cancer patients treated postoperatively with curative intent were selected. The actual target contours were then modified to reflect hypothetical target volumes which would have been used had the patients been treated preoperatively. Hypothetical preoperative treatment plans were generated for each patient based on these modified contours. The hypothetical preoperative treatment plans were then compared to the actual postoperative plans with respect to dose-volume parameters including lung mean dose, lung V20, heart V20 and V30, and mean doses to abdominal structures. Target volumes were smaller with preoperative treatment, with an average reduction of 23%. Comparative dose-volume histogram (DVH) analysis showed the resultant composite lung doses were reduced in the preoperative plans by 50-79%. In all patients, the proportion of lungs receiving at least 20 Gy (V20) was substantially reduced using preoperative treatment (1.9% vs. 9.7% in the 3-D conformal patient; mean of 3.1% vs. 17.6% in the intensity modulated radiation therapy patients). Likewise, the volume of heart receiving at least 30 Gy was dramatically reduced in all preoperative plans (15.8% vs. 35.4%). Doses to the kidneys, liver and spinal cord were comparable in both approaches. Preoperative treatment of GE junction and proximal gastric cancer patients offers the potential to decrease the radiation dose received by normal thoracic structures.
机译:局部区域复发发生在超过一半接受潜在治疗的胃癌患者中。辅助化学放疗可减少局部复发,但通常需要照射大视野,并且受患者耐受性差的限制。这项研究探索了术前而不是辅助放疗来治疗胃食管(GE)交界处/近端胃癌在减少对正常结构的辐射剂量方面的潜在剂量学益处。选择5例接受根治性治疗的GE结/近端胃癌患者。然后修改实际的目标轮廓,以反映假想的目标体积,如果患者在术前接受治疗,这些体积将被使用。根据这些修改后的轮廓为每个患者生成了假想的术前治疗计划。然后,将假设的术前治疗计划与实际的术后计划进行比较,以考虑剂量-体积参数,包括肺平均剂量,肺V20,心脏V20和V30以及腹部结构的平均剂量。术前治疗的目标体积较小,平均降低了23%。比较剂量-体积直方图(DVH)分析显示,在术前计划中,合成肺总剂量减少了50-79%。在所有患者中,术前治疗使接受至少20 Gy(V20)的肺部比例大大降低(3-D保形患者为1.9%对9.7%;强度调制放射线的平均值为3.1%对17.6%)治疗患者)。同样,在所有术前计划中,接受至少30 Gy的心脏体积均显着减少(分别为15.8%和35.4%)。在这两种方法中,肾脏,肝脏和脊髓的剂量均相当。 GE交界处和胃癌近端患者的术前治疗可降低正常胸腔结构接受的放射剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号